Company challenges melatonin sales banBMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7048.10a (Published 06 July 1996) Cite this as: BMJ 1996;313:10
- Clare Dyer
A pharmaceutical company that makes melatonin–hailed by the United States media as a miracle “anti-aging” product–is to challenge the Medicines Control Agency's ban on over the counter sales in Britain.
Pharma-Nord, based in Morpeth, Northumberland, will seek leave this month for a High Court judicial review of the ban. The agency claims that the product, which is made from soya beans, has medicinal properties and should not be sold without …